BACKGROUND

1. At all times relevant, the Respondent was licensed to practice as a respiratory
care practitioner ("RCP”) in the State of Maryland. The Respondent was initially
licensed in Maryland on or about July 2, 2010, and her license is scheduled to expire on
or about May 30, 2018.

2. At all times relevant, the Respondent was employed by Hospital A? in Baltimore,
Maryland, as a Respiratory Therapist.

3. The Respondent was employed at Hospital A from July 12, 2010 through May 5,
2016, when Hospital A terminated her from employment for reasons set forth below.

4. On or about May 16, 2016, Hospital A filed a Mandated 10-Day Report (the
“Report”) with the Board notifying the Board the Respondent's employment had been
terminated based on her diversion of intravenous (“IV”) fentanyl, a Schedule Il
controlled dangerous substance (“CDS”), from a patient’s IV bag.

5. After receiving notification of the Report, the Board initiated an investigation into
the allegations.

6. The Board’s investigation into the complaint as set forth below included issuing
subpoenas to obtain the Respondent's personnel and fitness for duty files from Hospital
A, obtaining treatment records, and conducting interviews of Hospital A’s staff and the
Respondent.

7. On or about July 6, 2016, the Board notified the Respondent of its investigation

and requested a response.

? In order to maintain confidentiality, facility, patient and employee names will not be used in this
document, but will be provided to the Respondent on request.
